MOLECULIN BIOTECH INC
MBRX·60855D408·US·Common Stock·Healthcare - Biotechnology-13D/G
MBRX (MOLECULIN BIOTECH INC) is held by 12 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($74,033), VANGUARD CAPITAL MANAGEMENT LLC ($31,760), VANGUARD FIDUCIARY TRUST CO ($13,905). Net institutional sentiment: Mixed.
12
Holders
Avg rating(2 Elite)
$138,936
Total Value
58% (15)
Fund Consensus
7 buying - 5 selling
Who's Trading
ActivistARArmistice Capital, LLC5.0%Aug 14, 2025
InsiderKVKLEMP WALTER VBuy $250KJun 23, 2025
InsiderFPFoster Jonathan P.Buy $100KJun 23, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer